title: Gemcitabine and cisplatin in patients with carcinoma of unknown primary site.
authors.affiliation: Department of Medical Oncology, Ankara Numune Education and Research Hospital, Sihhiye, 06100, Ankara, Turkey. metin1721978@yahoo.com
authors.forename: Metin
authors.initials: M
authors.lastname: Isik
authors.forename: Mehmet M
authors.initials: MM
authors.lastname: Seker
authors.forename: Hatice
authors.initials: H
authors.lastname: Odabas
authors.forename: Fahriye T
authors.initials: FT
authors.lastname: Kos
authors.forename: Dogan
authors.initials: D
authors.lastname: Uncu
authors.forename: Nurullah
authors.initials: N
authors.lastname: Zengin
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000188:drug therapy* / Q000401:mortality; D012189:Retrospective Studies; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D002945:Cisplatin; D000093542:Gemcitabine